- Home
- MTZ vs MEDP Comparison
MTZ vs MEDP Comparison
Compare MTZ & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTZ
- MEDP
- Stock Information
- Founded
- MTZ 1929
- MEDP 1992
- Country
- MTZ United States
- MEDP United States
- Employees
- MTZ N/A
- MEDP N/A
- Industry
- MTZ Water Sewer Pipeline Comm & Power Line Construction
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MTZ Industrials
- MEDP Health Care
- Exchange
- MTZ Nasdaq
- MEDP Nasdaq
- Market Cap
- MTZ 13.6B
- MEDP 13.4B
- IPO Year
- MTZ N/A
- MEDP 2016
- Fundamental
- Price
- MTZ $212.52
- MEDP $605.20
- Analyst Decision
- MTZ Strong Buy
- MEDP Hold
- Analyst Count
- MTZ 21
- MEDP 11
- Target Price
- MTZ $218.30
- MEDP $451.70
- AVG Volume (30 Days)
- MTZ 916.8K
- MEDP 376.1K
- Earning Date
- MTZ 10-30-2025
- MEDP 10-22-2025
- Dividend Yield
- MTZ N/A
- MEDP N/A
- EPS Growth
- MTZ 3211.19
- MEDP 25.36
- EPS
- MTZ 3.34
- MEDP 14.32
- Revenue
- MTZ $13,047,952,000.00
- MEDP $2,358,373,000.00
- Revenue This Year
- MTZ $14.77
- MEDP $19.15
- Revenue Next Year
- MTZ $9.26
- MEDP $8.91
- P/E Ratio
- MTZ $63.42
- MEDP $42.26
- Revenue Growth
- MTZ 7.08
- MEDP 13.88
- 52 Week Low
- MTZ $99.70
- MEDP $250.05
- 52 Week High
- MTZ $221.83
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- MTZ 57.88
- MEDP 77.57
- Support Level
- MTZ $190.01
- MEDP $528.50
- Resistance Level
- MTZ $215.72
- MEDP $625.00
- Average True Range (ATR)
- MTZ 9.01
- MEDP 19.24
- MACD
- MTZ -0.50
- MEDP 6.92
- Stochastic Oscillator
- MTZ 74.03
- MEDP 84.87
About MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.